Aarti Gill, co-founder of OZiva, discusses the decision not to raise venture capital during the startup's early struggling phase before finding product-market fit.
Opinion
Gill: There has been zero innovation in Indian OTC over 10 years
“Because I think in the last 10 years, there has been zero innovation in the OTC space, right?”
Assertion Partly supported
Gill: OZiva hit ₹150-180 crore revenue with a 140% 3-year CAGR
“Today, you know, we are predominantly sitting at between 150 to 180 CR, right? Our growth for the last three years, we've grown at a one 40% CAGR and I think over the last three, four years, 2.5 million people or 25 black people have used our products”
Insight
Gill: D2C websites and retail should be treated simply as fulfillment channels
“Even today, I look at my own D to C as a fulfillment channel, e-commerce as a fulfillment channel, and also a chemist as a fulfillment channel. If a person wants a chemist, he can buy it from there. If they buy it from Amazon or Flipkart, the product should be…”
Insight
Gill: Clean eating trends are adopted first by women globally
“Also, globally, what we realized was that, you know you know, clean eating as a concept, right, is, is a lot first adopted by women and In, in the global or in the Western market as well, which is where we saw the same kind of trend in India as well, right?”
Assertion Not checkable as stated
Gill: Scaled adult nutrition brands see max two repeat boxes yearly
“I think the age group between, I would say, 25 to 45 or 50, right? Where, which is where the retentions are not that great. Right. Where say even scaled up brands have seen maximum two boxes in an year being picked up.”
Disclosure
Gill: 20% of OZiva customers drop out after consulting uninformed doctors
“We saw that 20% of our people drop out because, you know, they go to a HCP and they say, I can take this regularly and not, right? And the HCP says, I don't know, I'm never, or, you know, I'm not sure.”